Danaher Corp to acquire Masimo for $9.9B
Masimo Corp will be acquired by Danaher Corp for $9.9 billion, according to multiple media reports including Reuters.
Tag: Masimo
All
Latest
Danaher Corp to acquire Masimo for $9.9B
Masimo Corp will be acquired by Danaher Corp for $9.9 billion, according to multiple media reports including Reuters.
Read More
Apple Ordered to Pay Masimo $634M Over Patent Infringement
A US-based jury ordered Apple to pay $634 million for infringing Masimo’s patent for blood oxygen monitoring technology in its Apple Watch.
Read More
Feasibility Study Assesses Pulse Oximeter Accuracy for Adult ICU Patients Across All Skin Tones
The INSPIRE Trial prospectively assesses pulse oximeter accuracy using a unique real-world study design and in the feasibility study showed no clinically significant bias between patients with light and dark skin tones and no occult hypoxemia.
Read More
Continuous Monitoring via Masimo Tech Reduced Costs
A study published in the Journal of Patient Safety demonstrated that use of Masimo technologies to continuously monitor general floor patients can yield significant cost savings, according to Masimo.
Read More
FDA Expands Clearance for Masimo O3 Regional Oximetry
Masimo’s O3 Regional Oximetry has received expanded FDA 510(k) clearance to include delta hemoglobin parameters for cerebral and somatic use across all patient populations.
Read More
Masimo Expands Patient Monitoring Partnership with Philips
Masimo and Royal Philips have agreed to a multi-year renewal and expansion of their strategic partnership focused on patient monitoring technologies.
Read More
Masimo EEG Brain Function Monitoring Reduced Pediatric Anesthesia Administration
EEG-guided anesthesia using Masimo technology significantly reduced pediatric anesthesia emergence delirium, time to emergence and discharge, and cost of care by minimizing sevoflurane exposure.
Read More
Masimo CEO Joe Kiani Resigns
Joe Kiani, the founder and longtime CEO of Masimo, has resigned following his ouster from the company’s board of directors, Reuters reports.
Read More
FDA Clears Masimo W1 Watch for Connectivity with Telemonitoring System
The Masimo W1 medical watch, now FDA-cleared for integration with Masimo SafetyNet, enables continuous remote monitoring of vital signs.
Read More
Masimo RPM Cut Rehospitalizations for Joint Replacement Patients
Masimo’s RPM (remote patient monitoring) technology helped reduce hospital readmissions and...
Read More
Masimo Adds Sleep Halo to its Smart Watch
Masimo will add scientifically-based sleep analysis to its Masimo W1 Sport advanced health tracking wearable by incorporating its Sleep Halo software.
Read More
FDA Clears Masimo’s Stork Baby Monitoring System for OTC Use
With the clearance, Stork is available for at-home monitoring of oxygen saturation, pulse rate, and skin temperature in babies without a prescription.
Read More
Masimo, UCHealth Partner on Telehealth
Masimo and UCHealth (Colorado) are entering into a strategic collaboration to improve the standard of patient care using the latest in virtual care and telehealth capabilities.
Read More
FDA Clears First Over-the-Counter Pulse Oximeter
The clearance makes it the first FDA-cleared medical fingertip pulse oximeter available OTC direct to consumers without a prescription.
Read More
Masimo Pulse Oximetry Demonstrates Accuracy for Black, White Skin Tones
Masimo’s RD SET pulse oximetry sensors accurately measured oxygen saturation for both Black and white subjects in normal and low perfusion conditions.
Read More
Apple to Remove Pulse Oximetry Feature from Certain Apple Watches
Apple will remove a blood oxygen monitoring feature from two Apple Watch models (Series 9 and Ultra 2) in the United States.
Read More
FDA Clears Masimo Stork Baby Monitoring System for Prescription Use
The FDA granted 510(k) clearance to Masimo’s Stork, a baby monitoring system, for prescription use with healthy and sick babies 0-18 months of age.
Read More
Correlation Between Masimo’s ORi and PaO2
Masimo’s ORi could provide useful information on arterial oxygenation even during one-lung ventilation, according to new research published in the Journal of Anesthesia.
Read More
FDA Clears Masimo Medical Watch for OTC and Prescription Use
Masimo W1 is the first FDA-cleared watch to provide continuous real-time oxygen saturation and pulse rate for over-the-counter and prescription use, according to Masimo.
Read More
GE Healthcare, Masimo Integrate Patient Monitoring Tech
GE Healthcare and Masimo signed a joint agreement to integrate Masimo SET pulse oximetry into GE Healthcare’s Portrait Mobile wireless and wearable patient monitoring solution.
Read More
ITC Rules Apple Can’t Sell Certain Watches That May Infringe Masimo Patents
The USITC has recommended a limited exclusion order for infringing Apple Watches with light-based pulse oximetry functionality, according to a news release from Masimo.
Read More
Masimo ORi Granted FDA De Novo
Masimo’s ORi is a noninvasive, continuous parameter designed to provide additional insight into a patient’s oxygen status in the moderate hyperoxic range under supplemental oxygen.
Read More
Masimo Gets CE Mark for LiDCO Module for Hemodynamic Monitoring
Masimo received the CE mark for the LiDCO board-in-cable module, designed to connect to multi-patient monitoring platforms to provide advanced hemodynamic monitoring.
Read More
Masimo Releases Stork Smart Home Baby Monitor
Masimo announced the full US market release of the Stork smart home baby monitoring system, which can detect babies’ oxygen saturation, pulse rate, and temperature with accuracy and dependability.
Read More